| Literature DB >> 32761278 |
Sofie Van Cauter1,2, Mariasavina Severino3, Rosamaria Ammendola3, Brecht Van Berkel4,5, Hrvoje Vavro6, Luc van den Hauwe7,8, Zoran Rumboldt9,10.
Abstract
The basal ganglia and thalami are paired deep grey matter structures with extensive metabolic activity that renders them susceptible to injury by various diseases. Most pathological processes lead to bilateral lesions, which may be symmetric or asymmetric, frequently showing characteristic patterns on imaging studies. In this comprehensive pictorial review, the most common and/or typical genetic, acquired metabolic/toxic, infectious, inflammatory, vascular and neoplastic pathologies affecting the central grey matter are subdivided according to the preferential location of the lesions: in the basal ganglia, in the thalami or both. The characteristic imaging findings are described with emphasis on the differential diagnosis and clinical context.Entities:
Keywords: Basal ganglia; Bilateral lesions; CT; MRI; Symmetric lesions; Thalamus
Mesh:
Year: 2020 PMID: 32761278 PMCID: PMC7405775 DOI: 10.1007/s00234-020-02511-y
Source DB: PubMed Journal: Neuroradiology ISSN: 0028-3940 Impact factor: 2.804
Fig. 1Leigh syndrome. A 6-year-old girl with Leigh syndrome in the acute phase. a Axial T2-weighted image at the basal ganglia level shows bilateral symmetric hyperintensity of the striatum and focal medial thalamic lesions (arrows). There is slightly increased signal intensity of globi pallidi. b Axial T2-weighted image through the midbrain demonstrates hyperintensity of the tectum, periaqueductal grey matter (arrowhead) and bilateral substantia nigra. On MR spectroscopy with echo time of 144 ms, lactate was detected as an inverted double peak on 1.33 ppm (not shown)
Fig. 2Leigh syndrome. A 4-year-old boy with Leigh syndrome. Axial FLAIR image reveals bilateral symmetric hyperintensity in the dorsal putamen. There are additional symmetric brainstem lesions (not shown)
Fig. 59Summary overview of most pathologies listed in this review paper. Predominantly involving the basal ganglia. Leigh Sy—BL symmetric BG and brainstem (+/− thalami); glutaric aciduria type 1—BL BG and WM + wide Sylvian fissures; WD—BL symmetric striatum on T2w (+/− brainstem and thalami), GP on T1w; HD—BL atrophy of striatum—“boxed-out” frontal horns; PKAN—BL GP “eye of the tiger” sign; CO poisoning—BL focal GP lesions; kernicterus—BL GP (+ subthalamic nucleus); chronic HE/Mn/Gd deposition—BL GP on T1w; methanol poisoning—BL putamen (+ haemorrhage) and frontal WM; uremic encephalopathy/metabolic acidosis—BL lentiform fork sign; hypoglycaemia—BL BG and diffuse cortical GM on DWI; hyperglycaemia—unilateral striatum on T1w and CT; autoimmune encephalitis—BL striatum (+/− hippocampi and other areas); cryptococcosis—scattered focal BL BG lesions; germinoma—UL or BL on T2*w, hemiatrophy. Predominantly involving the thalami. Gangliosidosis—T1 bright and T2 dark thalami; toluene toxicity—T2 dark thalami and hyperintense WM, atrophy; WE—BL paramedial thalami (+ periaqueductal GM and mammillary bodies); acute hyperammonaemia—BL GM of insula, cingulate and thalami; ANE—BL concentric haemorrhagic thalamic lesions; artery of Percheron infarction—BL focal thalamic infarcts (+/− midbrain); DCVT—thalamic swelling with haemorrhage and venous thrombosis; bithalamic glioma—prominent mass effect. Affecting the basal ganglia and thalami. Tubulinopathy—fused malformed BG + other findings; NF-1 FASI—scattered patchy ill-defined; EG poisoning—BL BG and thalami; vigabatrin-associated MRI changes—BL thalami and BG (+ brainstem and dentate nuclei); CJD—BL or UL striatum and cortex (+/− thalami—“hockey stick” sign) on DWI; ADEM—asymmetric central GM and WM; viral encephalitis—asymmetric central and cortical GM; toxoplasmosis—eccentric and concentric target sign; HIE adult—symmetric central and cortical GM on ADC; HIE neonate—absent PLIC, T1 bright central GM; PRES—BL WM and GM oedema. ADEM, acute disseminated encephalomyelitis; AIE, autoimmune encephalitis; AoP, artery of Percheron; ANE, acute necrotising encephalitis; BG, basal ganglia; BL, bilateral; CJD, Creutzfeldt–Jakob disease; CO, carbon monoxide; DCVT, deep cerebral venous thrombosis; FASIs, focal abnormal signal intensities; GA, glutaric aciduria; GM, grey matter; GP, globus pallidus; HD, Huntington disease; HIE, hypoxic–ischaemic encephalopathy; PKAN, pantothenate kinase-associated neurodegeneration; PRES, posterior reversible encephalopathy syndrome; UL, unilateral; WD, Wilson disease; WE, Wernicke encephalopathy; WM, white matter
Fig. 3Glutaric aciduria type 1. A 14-year-old male with glutaric aciduria type 1. a On axial T2-weighted image, there is bilateral symmetric hyperintensity of the posterior lentiform nuclei (arrows). b Confluent fronto-temporo-parietal areas of high signal intensity (white arrowheads) are better seen on the coronal T2-weighted image, which also demonstrates subependymal nodules (black arrowheads) along the superior aspect of the frontal horns
Fig. 4Glutaric aciduria type 1. A 20-month-old boy with glutaric aciduria type 1. a Axial T2-weighted image shows subcortical areas of delayed myelination, primarily frontal (arrowheads), along with more prominent bilateral symmetric hyperintensity of the globi pallidi and posterior putamina (arrows). b ADC map reveals lower signal intensity of the lentiform nuclei (arrows), consistent with decreased diffusivity. There are also bilateral wide opercula/enlarged Sylvian fissures (*), best seen on the left side in a
Fig. 5Wilson disease. A 6-year-old girl with headache, tremor and liver failure. a Axial T2-weighted image reveals bilateral symmetric hyperintensity of the putamen and caudate nucleus, more prominent peripherally. There is a subtle increase in signal intensity in bilateral globus pallidus and lateral thalamus. b Axial T1-weighted image at a slightly lower level shows bilateral mild decrease in signal intensity of the putamen and hyperintensity of globus pallidus (arrows)
Fig. 6Huntington disease. A 36-year-old male patient with a family history of Huntington disease and choreoathetosis. There is severe atrophy of the caudate nucleus head on coronal post-contrast T1-weighted image with frontal horns of the lateral ventricles demonstrating “boxed-out” appearance (arrowheads). There is also atrophy of the frontal lobes
Fig. 7Huntington disease. A 17-year-old patient with a juvenile form of the disease. Axial T2-weighted image shows a reduced size of bilateral caudate head (arrowheads) and putamen (arrows). The associated hyperintensity is more prominent in the putamina
Fig. 8PKAN. An 8-year-old boy with pantothenate kinase-associated neurodegeneration. a Bilateral symmetric hyperintense foci in the anteromedial globus pallidus are surrounded by lower signal intensity on FLAIR image (arrows), giving the typical “eye of the tiger” sign. b There is a corresponding mild hyperintense signal on T1-weighted image
Fig. 9Carbon monoxide (CO) poisoning. A 37-year-old fire victim with headache, nausea and vomiting. Axial CT shows bilateral focal hypodense lesions within globus pallidus (arrows)
Fig. 10CO poisoning. Acute CO intoxication from malfunctioning heater. Axial FLAIR image shows hyperintense oval lesions in bilateral globus pallidus with central hypointensity (suggestive of small haemorrhage). There are also white matter hyperintensities (arrowheads), more extensive in the centrum semiovale (not shown)
Fig. 11Kernicterus. A 4-year-old boy with chronic bilirubin encephalopathy. T2-weighted image reveals symmetric hyperintensity of the globi pallidi. Symmetric increased signal was also present at the dentate and subthalamic nuclei (not shown)
Fig. 12Chronic liver failure/Mn toxicity. A 49-year-old female with known hepatic cirrhosis presenting with new onset tremor. On axial T1-weighted image, there is symmetric hyperintensity of the globi pallidi. The increased signal is extending to the tegmentum of the midbrain and dentate nuclei (not shown). There is also increased T2 signal intensity in the internal capsules (not shown)
Fig. 13Methanol poisoning. A 31-year-old man a few days after ingestion of home-made liquor. a Axial FLAIR image shows bilateral symmetric hyperintensity with mild swelling of the putamen and frontal white matter. The signal alteration is accentuated along the lateral putaminal margin (arrowheads), and there are a few additional smaller hyperintense areas. b ADC map at a slightly lower level reveals high diffusivity of the putamina (arrowheads) and reduced diffusion of the affected white matter (arrows), predominantly frontal. Images courtesy of Claudia Godi
Fig. 14Uremic encephalopathy/metabolic acidosis. A 2-year-old girl admitted with vomiting and diarrhoea for 1 week. Laboratory findings confirmed haemolytic uremic syndrome. a Axial FLAIR image shows bilateral symmetric swelling and increased signal of the central and posterior putamina with a more prominent hyperintense rim along the medial and lateral margins (arrows)—the characteristic “lentiform fork” sign of uremic encephalopathy and metabolic acidosis. There is also a small white matter signal alteration. b The lesions show centrally reduced (arrowheads) and peripherally (along the medial and lateral arms of the putamina) increased diffusivity (arrows) on the corresponding ADC map
Fig. 15Hypoglycaemia. A 77-year-old woman with diabetes mellitus following a suicide attempt with insulin overdose, resulting in hypoglycaemic coma. a The entire visualised cerebral cortex and striatum show bilateral hyperintense signal on axial FLAIR image. b Corresponding ADC map reveals reduced diffusivity of the involved grey matter. The globi pallidi and thalami (*) are spared
Fig. 16Hyperglycaemia. A 79-year-old woman presenting with left-sided hemichorea-hemiballismus. Laboratory findings confirmed non-ketotic hyperglycaemia in this patient with known diabetes. a Axial CT image shows high attenuation of the entire right putamen (arrow) and caudate head (arrowhead) without expansion. b MRI demonstrates hyperintensity of the right putamen on T1-weighted imaging
Fig. 17Autoimmune encephalitis. A 46-year-old man with gait instability, behavioural disorder and chorea. Axial T2-weighted image demonstrates bilaterally symmetric hyperintensity and mild swelling centred at the putamen (arrows) and caudate nucleus (arrowheads). A slight symmetric increase in signal intensity is present at the cingulate gyri and posterior thalami. Anti-CV2/CRMP5 antibodies tested positive and metastatic lung cancer was eventually diagnosed
Fig. 18Cryptococcosis. HIV-positive patient with headaches, nausea and vomiting. a Axial FLAIR image shows asymmetric patchy hyperintense lesions in bilateral basal ganglia. b There are focal areas of enhancement within these lesions on corresponding post-contrast T1-weighted image
Fig. 19Germinoma. A 14-year-old boy with cognitive and behavioural changes, headaches and progressively worsening weakness of the right arm and leg. Axial T2-weighted image shows left greater than right hyperintense lesions in the basal ganglia with prominent peripheral hypointensity (arrows). There is also left hemiatrophy with widened Sylvian fissure (*) and atrium of the lateral ventricle (**). Courtesy of Andrea Rossi
Fig. 20Lysosomal storage disorders—GM1 and GM2 gangliosidoses. A 17-month-old girl with the infantile form of gangliosidosis type 1. a There is bilateral hyperintensity of the thalami (arrows) on T1-weighted image. b T2-weighted image shows corresponding low signal intensity of the thalami (arrows). There is also diffuse hypomyelination of the supratentorial white matter (with low T1 and high T2 signal intensity) and plagiocephaly
Fig. 21Toluene toxicity. A 21-year-old male with organic solvent abuse for 5 years. Axial T2-weighted image shows a prominent hypointensity of both thalami (arrows). Also seen is mildly decreased signal intensity of the left globus pallidus, generalised atrophy and diffusely increased signal of the white matter with loss of grey–white matter distinction. Case courtesy of Dr. Chee Kok Yoon, Radiopaedia.org, rID: 17082
Fig. 22Wernicke encephalopathy (WE). A 38-year-old female with history of gastric bypass, presenting with somnolence and ophthalmoplegia after 3 days of vomiting and Wernicke encephalopathy. a, b Axial FLAIR images demonstrate hyperintensity involving bilateral medial thalami along the third ventricle, periaqueductal grey matter (arrowhead) in the midbrain and the mammillary bodies (arrows)
Fig. 23WE. A 49-year-old male with WE due to chronic alcoholism. a Axial DWI shows the characteristic bilateral symmetric hyperintensity along the dorsomedial thalami (arrows). b There is no diffusion abnormality on the corresponding ADC map
Fig. 24Acute hyperammonaemic encephalopathy. A 26-year-old man was found unconscious, with upper motor neuron signs, clonus and drowsiness on exam. Biochemical exam demonstrated hyperammonaemia due to valproate toxicity. Coronal FLAIR image reveals bilateral symmetric high signal intensity involving the cortex of insula and cingulate (arrows), thalami (arrowheads) and hippocampi. Courtesy of Sumeet Kumar
Fig. 25Acute hyperammonaemic encephalopathy. A 60-year-old alcoholic patient presenting with confusion and drowsiness due to decompensated liver cirrhosis. a There is bilateral symmetric cortical and thalamic (arrows) hyperintensity on DWI. The cortical signal alteration is most prominent in the cingulate gyri and insulae, while the occipital lobes and basal ganglia are spared. The perirolandic cortex is also spared (not shown). b Corresponding T1-weighted image shows bilateral high signal of globus pallidus (arrowheads), indicative of chronic liver failure. Case courtesy of Dr. Andrew Dixon, Radiopaedia.org, rID: 39037
Fig. 26Acute necrotising encephalitis (ANE). A 2-year-old girl with drowsiness following respiratory viral infection. a Axial ADC map shows swelling of both thalami with heterogeneous diffusivity—primarily central low and peripheral high signal. b The central areas show signal loss (arrows) on the corresponding GRE T2* image, consistent with haemorrhage. Normal appearance of the internal cerebral veins, without signs of thrombosis
Fig. 27Artery of Percheron infarction. A 69-year-old female patient found unconscious. a Axial non-enhanced CT image shows subtle hypodense lesions (arrows) in both thalami. The lesions are bright on DWI (b) and dark on ADC map (c), consistent with reduced diffusivity of acute infarctions
Fig. 28Artery of Percheron infarction. Well-defined bilateral CSF-like hypodense lesions at centromedial thalami (arrowheads) represent chronic infarctions
Fig. 29Deep cerebral venous thrombosis (DCVT). A 6-month-old boy with loss of consciousness. a Non-enhanced axial CT image demonstrates right greater than left bithalamic hyperdense lesion consistent with blood clot. There is mild mass effect and surrounding low attenuation (arrowheads) in the right thalamus. The blood clot appears contiguous with the hyperdensity (arrows) extending into the vein of Galen. b Reformatted midsagittal CT image confirms DCVT by depicting the prominent hyperdensity of the internal cerebral veins, vein of Galen (arrowhead) and straight sinus, as well as the inferior sagittal sinus (arrow)
Fig. 30DCVT. Term neonate with deep venous thrombosis. a There is bilateral swelling of the thalami with predominantly low signal intensity (arrowheads) on axial T1-weighted image. Left greater than right central hyperintense area is indicative of haemorrhage. Additionally, there is high signal intensity at the vein of Galen (arrow), suggestive of thrombosis. b MR venography reveals the absence of signal in the internal cerebral veins, vein of Galen and straight sinus, confirming DCVT
Fig. 31Bithalamic glioma. A 44-year-old male with dizziness, left face paraesthesia and weakness in the left side of body. a Axial T2-weighted image shows right greater than left expansion of the thalami with mildly heterogeneous increased signal intensity. b Corresponding ADC map reveals heterogeneous nature of the mass lesion with predominantly increased and peripherally reduced (arrows) diffusivity
Fig. 32Primary CNS lymphoma. A 46-year-old male with headache, collapse and vomiting. a, b Non-enhanced axial CT images show hyperdense lesions along the medial thalami (arrows) with adjacent low attenuation. An additional subependymal hyperdense lesion (arrowheads) is present along the frontal horn of the right lateral ventricle. There is also dilation of the ventricles with periventricular oedema and effacement of cortical sulci, consistent with acute hydrocephalus
Fig. 33Tubulinopathy. A 10-year-old girl with mental retardation. There is a dysmorphic appearance of bilateral basal ganglia with fused and malformed caudate nucleus and putamen (arrowheads) on axial T1-weighted image. The thalami are hypoplastic (arrows). There is pachygyria in the insular regions along with the absence of the corpus callosum, Z-shaped brainstem and hypoplasia of the vermis and cerebellum (not shown)
Fig. 34Tubulinopathy. A 1-month-old girl with failure to thrive. The basal ganglia appear as large round structures with fusion of the caudate and putamen (arrowheads) on axial T2-weighted image. The thalami are slightly asymmetric
Fig. 35Focal abnormal signal intensities (FASIs) in NF-1. An 8-year-old boy with confirmed diagnosis of neurofibromatosis type 1 on genetic testing. a Axial FLAIR image demonstrates patchy bilateral focal abnormal signal intensities (FASIs) in the globi pallidi (arrowheads) and the posterior thalami (arrows). b On T1-weighted image, some of the lesions appear slightly hyperintense. c Axial T2-weighted image shows additional FASIs in the cerebellum (arrows)
Fig. 36FASIs in NF-1. Asymmetric ill-defined patchy hyperintensities consistent with FASIs (arrows) are seen in the basal ganglia and thalami on axial T2-weighted image
Fig. 37Primary familial brain calcification. A 30-year-old male with primary familial brain calcification (PFBC). Axial CT image demonstrates extensive calcifications in the basal ganglia, thalami and subcortical white matter. The putamina appear atrophic. There are also cerebellar calcifications in bilateral corpus medullare (not shown)
Fig. 38Primary familial brain calcification. A 57-year-old male with PFBC. Calcifications of the basal ganglia (arrows) and thalamus (arrowheads) are predominantly hyperintense on this sagittal T1-weighted image
Fig. 39Ethylene glycol intoxication. A 25-year-old male found unconscious at home, after having his drink spiked with ethylene glycol (anti-freeze) the night before. The initial CT scan was unremarkable (not shown). a MRI 2 days later demonstrates bilateral symmetric swelling and hyperintensity in the basal ganglia and thalami on axial FLAIR image. The signal alteration is more prominent along the lateral margin of the putamina, with a suggestion of the lentiform fork sign on the right side (arrow). b Axial T2-weighted image through the pons shows increased signal and mild swelling of the dorsal brainstem (arrowheads) extending to the right middle cerebellar peduncle
Fig. 40Osmotic demyelination syndrome (ODS)—extrapontine myelinolysis (EPM) and central pontine myelinolysis (CPM). A 46-year-old man with a background of alcohol abuse presented with hyponatraemia, which was corrected and followed by increasing neurological deficits, including quadriparesis and loss of consciousness. a Axial T2-weighted image at the basal ganglia level shows bilateral symmetric high signal intensity of the putamen and caudate head. There are also subtle hyperintensities in both thalami. b Axial T1-weighted image through the posterior fossa reveals a hypointense lesion in the pons with “trident” appearance (arrow), characteristic for CPM
Fig. 41ODS—extrapontine myelinolysis (EPM). A 7-year-old girl with a background of leukaemia presented with fever, vomiting and horizontal nystagmus. Hyponatraemia was established on admission and promptly adjusted. There is bilateral symmetric swelling and hypodensity of the basal ganglia centred at the caudate head and anterior lentiform nucleus (arrows) on non-enhanced axial CT image
Fig. 42Brain MRI changes with vigabatrin therapy. A 50-week-old girl with infantile spasms treated with vigabatrin. a, b Axial T2-weighted images demonstrate bilateral symmetric hyperintensity of the thalami (arrowheads), basal ganglia (arrows), dentate nuclei (arrowheads) and brainstem (arrows). There is no associated mass effect. The findings were asymptomatic and resolved completely following discontinuation of vigabatrin. Courtesy of Kshitij (Kish) Mankand
Fig. 43Brain MRI changes with vigabatrin therapy. A 42-week-old girl treated with vigabatrin for epileptic encephalopathy. a There is decreased diffusivity of the thalami with low signal (arrows) on axial ADC map. b DWI at a lower level shows hyperintensity of the globi pallidi (arrows). Courtesy of Kshitij (Kish) Mankand
Fig. 44Hyperparathyroidism. A 28-year-old male presented with new-onset tremor and hyperparathyroidism was established on laboratory testing. a, b CT demonstrates symmetric dense calcifications in the globi pallidi and dentate nuclei
Fig. 45Creutzfeldt–Jakob disease (CJD). A 69-year-old male with a 5-month history of progressive generalised weakness, aphasia and cognitive decline and confirmed Creutzfeldt–Jakob disease (CJD). Axial DWI shows high signal intensity of bilateral striatum and dorsomedial thalami (“hockey stick” sign, arrowheads). There are also areas of cortical hyperintensity in the right operculum, as well as in bilateral insulae and cingulate gyri (arrows)
Fig. 46CJD. A 61-year-old female with rapidly progressive dementia, progressive motor and sensory impairment. CJD was confirmed. There is hyperintensity of bilateral basal ganglia, thalami and occipital cortices, along with partial temporal cortex involvement on axial DWI
Fig. 47ADEM. A 4-year-old girl presented with behavioural change and seizure following upper respiratory infection. a Axial T2-weighted image at the basal ganglia level reveals focal high signal intensity of the dorsal right thalamus (arrowhead). There are also hyperintense white matter changes in the right temporal and left occipital lobes (arrows). b The lesions demonstrate increased diffusivity on the corresponding ADC map (arrows)
Fig. 48West Nile viral encephalitis. A 71-year-old male with severe headache, high fever, disorientation, tremors and abnormal movements due to West Nile virus encephalitis. Coronal FLAIR image shows hyperintensity of the right thalamus (arrow), right periopercular fronto-insulo-temporal region, bilateral hippocampi and left uncus
Fig. 49EBV viral encephalitis. A 6-year-old boy with Epstein–Barr virus encephalitis. There is a hyperintense lesion with mild mass effect involving the left caudate head and ventral putamen (arrow) on axial FLAIR image. Furthermore, there are cortical lesions of high signal intensity in bilateral cingulate gyri and right insula (arrowheads)
Fig. 50Cerebral toxoplasmosis. A 32-year-old man with known HIV infection and a 5-day history of increasing confusion, headache and fever. Axial post-contrast T1-weighted image demonstrates an oval enhancing lesion at the left basal ganglia with surrounding vasogenic oedema and prominent mass effect. The enhancement is peripheral with an internal nodular extension (arrow), representing the “eccentric target” sign of toxoplasmosis
Fig. 51Cerebral toxoplasmosis. A 38-year-old woman presenting with fever, headache, blurred vision, seizures and left-sided weakness was found to be HIV positive. a There are at least three areas of vasogenic oedema in this axial FLAIR image. Within the oedema of the right hemisphere, there is a round retrolenticular lesion with internal layers—concentric alternating hypointense and hyperintense areas (arrow). This characteristic appearance represents the “concentric target” sign of toxoplasmosis
Fig. 52Hypoxic–ischaemic encephalopathy (HIE). A 44-year-old female following resuscitation after ventricular fibrillation and cardiac arrest. a There is bilateral hyperintensity of the striatum and predominantly posterior cortical grey matter, along with focal thalamic lesions (arrows) on axial DWI. The lesions are so diffuse and widespread that the image might even appear normal (with a wider window setting), except for the fact that the globi pallidi (*) and most of the thalami are spared and not as bright. b There is reduced diffusivity of the lesions on corresponding ADC map (arrows), consistent with cytotoxic oedema. In contrast to most other clinical settings, the abnormally low ADC signal is actually more conspicuous than the DWI hyperintensity
Fig. 53HIE. Term neonate with peripartal asphyxia and convulsions. a There is bilateral decreased diffusivity with low ADC values compatible with cytotoxic oedema in the globi pallidi and ventrolateral thalami (arrows). b There is absence of the normal high signal in the myelinated PLIC (arrows), which should be present in a term neonate on axial T1-weighted image. This is known as the “absent posterior limb” sign
Fig. 54HIE. A 5-day-old term neonate with severe perinatal asphyxia. a Axial T1-weighted and b T2-weighted images demonstrate bilateral symmetric signal alteration in the ventrolateral thalami, globi pallidi and posterior putamina, which are hyperintense (arrows) and hypointense, respectively. The findings are compatible with HIE. Note the bilateral high T1 signal of myelin in the posterior limb of the internal capsule (PLIC), which is normal in neonates after 37 weeks of gestational age
Fig. 55Hypertensive haematomas. A 75-year-old female presenting with left hemiparesis and Glasgow coma score (GCS) 6. Non-enhanced axial CT image shows right greater than left hyperdense lesions (arrows) at the lentiform nucleus and posterior limb of the internal capsule with a thin rim of low attenuation, consistent with acute hypertensive haematomas
Fig. 56Hypertensive haematomas. A 59-year-old male with sudden loss of consciousness. a There are left greater than right acute hypertensive haemorrhages centred at putamina on this non-enhanced axial CT image. There are also adjacent surrounding areas of low attenuation, consistent with extruded serum and oedema around the blood clot, and a prominent mass effect on the left. b Follow-up T2-weighted image 2 years later reveals corresponding slit-like lesions with peripheral hypointensity (arrowheads) representing haemosiderin staining
Fig. 57Posterior reversible encephalopathy syndrome (PRES). A 2-month-old boy with PRES. a Axial T2-weighted image reveals bilateral confluent hyperintense areas in the cortico-subcortical parieto-occipital regions (arrows) along with right greater than left involvement of the globi pallidi (arrowheads). b The lesions are predominantly showing increased diffusivity with high signal on the corresponding ADC map representing vasogenic oedema. There are, however, a few small cortical areas of reduced diffusivity (arrows) indicative of cytotoxic oedema
Fig. 58PRES. A 68-year-old male presenting with mental status change, headache, ataxia and dizziness. High blood pressure on exam. a There are scattered hyperintense lesions in bilateral caudate heads, lentiform nuclei (arrowheads), thalami (arrows) and periventricular white matter on axial FLAIR image. b Corresponding ADC map shows mildly increased diffusivity of the lesions, best seen in the thalami (arrows)
A summary overview listing the clinical, imaging and biochemical findings in the disease entities discussed in this paper
| Deep grey matter lesions | Imaging findings | Clinical findings | Biochemistry | |
|---|---|---|---|---|
| Characteristic | Common or possible | |||
| a. Predominantly involving the basal ganglia | ||||
| Leigh syndrome | BL symmetric putamen (+/− brainstem) T2 hyperintensity Reduced diffusivity in acute phase | BL symmetric T2 hyperintensity subthalamic nucleus, substantia nigra, caudate nucleus, globus pallidus, dorsomedial thalamus, dentate nuclei | Progressive neurodegeneration in infancy and early childhood—feeding difficulties, psychomotor retardation, ataxia | Mitochondrial disease, mutations in > 75 genes; elevated lactate |
| Glutaric aciduria type 1 | BL symmetric caudate and putamen T2 hyperintensity + wide Sylvian fissures, subdural hygromas and delayed myelination | Confluent WM T2 hyperintensity Subependymal nodules along lateral ventricles Macrocephaly | Acute encephalopathy in infancy precipitated by infection, immunisation or surgery—psychomotor regression with dystonia; insidious without crises | Deficiency of glutaryl-CoA dehydrogenase—newborn screening; metabolite levels, enzyme analysis, two mutations |
| Wilson disease | BL symmetric putamen and caudate T2 hyperintensity (concentric-laminar) BL symmetric GP T1 hyperintensity | Brainstem and thalami T2 hyperintensity—midbrain with sparing of red nuclei and superior colliculi produces “face of the giant panda” | Extrapyramidal and behavioural symptoms Kayser–Fleischer ring around the iris | ATP7B gene mutations—copper accumulation; low ceruloplasmin levels, high urine copper |
| Huntington disease | BL symmetric atrophy of putamen and caudate head—“boxed-out” frontal horns | BL symmetric caudate and putamen T2 hyperintensity in juvenile-onset HD; diffuse atrophy, primarily frontal, in advanced stages | Triad of motor, cognitive and psychiatric symptoms; adult-onset HD typically hyperkinetic, juvenile form hypokinetic motor disorder | Mutant (multiple CAG repeats) huntingtin protein aggregates in axonal terminals; direct genetic test |
| PKAN | BL symmetric GP T2 hypointensity with central hyperintensity—“eye of the tiger” sign | Generalised atrophy | Progressive dystonia, spasticity, dysarthria and vision loss | Two PANK2 gene mutations |
| Carbon monoxide | Globus pallidus and cerebral WM BL focal T2 hyperintense lesions, reduced diffusivity | BL cerebellar, hippocampal and other deep GM lesions; haemorrhage; cerebral WM reduced diffusivity with delayed leukoencephalopathy | Nausea, headache and dizziness to confusion and loss of consciousness; delayed leukoencephalopathy days to weeks later | Elevated blood levels of carboxyhaemoglobin (HbCO) |
| Bilirubin encephalopathy | BL symmetric GP and subthalamic nucleus T2 hyperintensity—chronic; BL symmetric GP and subthalamic nucleus T1 hyperintensity—acute | BL symmetric substantia nigra and cerebellar nuclei T2 hyperintensity in chronic phase | Infants with severe jaundice, poor feeding, lethargy, hypertonia or hypotonia, apnea | Very high bilirubin blood levels |
| Chronic hepatic encephalopathy/manganese toxicity | BL symmetric GP T1 hyperintensity | BL symmetric dentate nucleus, substantia nigra, subthalamic nucleus and tectum T1 hyperintensity; corticospinal tracts T2 hyperintensity | Neuropsychiatric abnormalities in the setting of cirrhosis and portal hypertension or portal-systemic shunts | Elevated serum ammonia levels High levels of manganese |
| Methanol | BL symmetric (dorsolateral) putamen and fronto-insular WM T2 hyperintensity; haemorrhage and reduced diffusivity | BL involvement of other basal ganglia, including isolated GP; (peripheral) contrast enhancement | Acute visual disturbances followed by headache, nausea, fatigue, abdominal pain; seizures and coma | Severe metabolic acidosis with high anion gap and increased osmolal gap |
| Uremic encephalopathy/metabolic acidosis | BL symmetric putamen and GP T2 hyperintense swelling with even higher signal of the rim and medullary laminae—“lentiform fork” sign | Increased diffusivity along “the fork”; central areas of reduced diffusivity: caudate may be involved | Nausea, vomiting, fatigue, anorexia, muscle cramps, pruritus, mental status changes; most commonly in end-stage renal disease | Very low glomerular filtration rate and creatinine clearance (generally under 10–15 mL/min) |
| Hypoglycaemia | BL symmetric BG and diffuse cortical GM reduced diffusivity and/or WM—posterior limb of internal capsule and splenium of corpus callosum | BL subcortical WM; UL lesions BL occipito-parietal GM and WM in neonates | Anxiety, dysarthria, confusion, loss of consciousness, seizures, coma; may simulate stroke | Very low plasma glucose concentration |
| Hyperglycaemia | UL putamen (+/− caudate and GP) CT hyperdensity and T1 hyperintensity | Asymmetric in very rare BL cases | Hemichorea-hemiballismus (continuous irregular and involuntary jerky movements on one side) in patients with poorly controlled diabetes mellitus | Elevated blood glucose level and glycosylated haemoglobin (HbA1c) |
| Autoimmune encephalitis | BL putamen and caudate T2 hyperintensity | Involvement of BL hippocampi and other limbic structures | Chorea and behavioural disorders | Anti-CV2/CRMP5 antibodies (or other antibodies against neuronal antigens) |
| Cryptococcosis | BL scattered focal CSF-like T2 hyperintense BG lesions, some of which enhance with contrast | Surrounding oedema; lesions in adjacent areas; ventriculomegaly | Usually insidious onset in HIV-positive and other immunosuppressed patients with headache, fever and malaise | Serum or CSF cryptococcal polysaccharide antigen (CrAg); CSF or blood culture |
| Germinoma | UL or BL asymmetric GP and putamen SW-MRI or T2* hypointense lesions; ipsilateral hemiatrophy in UL cases | Cysts, calcification, haemorrhage, mass effect; subtle CT hyperdensity, T1 and T2 hyperintensity | Slowly progressive hemiparesis, psychosis and cognitive decline in the second decade of life | Elevated human chorionic gonadotropin (hCG) in some cases |
| b. Predominantly involving the thalami | ||||
| Gangliosidosis (GM1 and GM2) | BL symmetric thalamus T2 hypointensity and T1 hyperintensity, CT hyperdensity (infantile form, also other lysosomal storage diseases); cerebellar atrophy (adult and juvenile forms) | BL symmetric putamen and caudate mild T2 hyperintensity, diffuse hypomyelination with sparing of corpus callosum | Rapidly evolving motor weakness, developmental delay, deafness and blindness (infantile form); motor disturbances and intellectual disabilities (adult and juvenile forms) | Measurement of lysosomal enzyme activity in blood samples; detection of genetic mutations |
| Toluene toxicity | BL symmetric thalamus T2 hypointensity, BL WM T2 hyperintensity, loss of WM–GM differentiation, global atrophy | BL basal ganglia and cortex T2 hypointensity | Insomnia, cerebellar dysfunction, secondary Parkinsonism, visual and hearing loss, attention deficit, memory dysfunctions and visuospatial impairment, dementia | No definite laboratory test Liver enzymes may be elevated; urinary metabolite (hippuric acid) with a high level of chronic use |
| Wernicke encephalopathy | BL symmetric dorsomedial thalamus, periaqueductal GM and mammillary body T2 hyperintensity, best seen on FLAIR and DWI | Contrast enhancement may be present; BL symmetric perirolandic cortex and cranial nerve nuclei T2 and DWI hyperintensity (non-alcoholic WE) | Classic triad: confusion, ataxia and ophthalmoplegia; nystagmus, delirium, hypotension Malnutrition—alcoholic and non-alcoholic | No definite laboratory test; frequent lactic acidosis |
| Acute hyperammonaemic encephalopathy | BL symmetric cortical GM of insula and cingulate gyrus T2 hyperintensity, best seen on FLAIR and DWI | BL symmetric thalamus T2 hyperintensity; reduced diffusivity may be present | Progressive drowsiness and seizures; liver disease, other conditions causing increased ammonia production or decreased elimination, including urea cycle defects (in paediatric patients) | Elevated serum ammonia level; serum amino acid levels, urinary tests and DNA mutation analysis for urea cycle defects |
| Acute necrotising encephalopathy | BL symmetric thalamus concentric haemorrhagic lesions (SW-MRI/T2*), centrally low and peripherally increased diffusivity | Brainstem lesion (even without thalamic involvement), subinsular areas, cerebellum and BG | Respiratory viral infection followed by acute encephalopathy with seizures and rapid alteration of consciousness, mostly in young children; also recurrent and familial forms | No specific laboratory test; usually elevated CSF protein, serum transaminase levels; mutations in RANBP2 gene (recurrent and familial forms) |
| Artery of Percheron infarction | BL paramedian thalamus focal infarcts—CT hypodensity, reduced diffusivity, T2 hyperintensity | Midbrain involvement: “midbrain V” sign—high signal on FLAIR extends BL along the interpeduncular cistern | Acute visual disturbances, confusion and coma Predominantly cardioembolic stroke | No specific laboratory test |
| Deep cerebral venous thrombosis | BL usually asymmetric thalamus swelling—T2 hyperintense and CT hypodense, frequent haemorrhage; CT hyperdense deep venous structures | BL symmetric or strikingly asymmetric (almost UL); BG, internal capsule, midbrain, upper cerebellum involvement | Acute to chronic headache, intracranial hypertension, focal neurological deficits, seizures, encephalopathy Predominantly in young women | Hypercoagulable panel, evaluation of risk factors |
| Dural arterio-venous fistula | BL thalamus mild swelling, T2 hyperintensity and increased diffusivity; dAVF diagnosed on DSA | Microbleeds may be present on SW-MRI; BL thalamus mild CT hypodensity; possible signs of dAVF on CTA and MRI | Rapidly progressive dementia | No specific laboratory test |
| Diffuse midline glioma/thalamic glioma | UL or BL thalamus, sometimes symmetric; prominent mass effect, T2 hyperintensity | Variable contrast enhancement, variable diffusivity | Headache and vomiting (hydrocephalus), motor deficits, confusion | Mutations in EGFR oncogene (BL thalamic glioma); H3K27M mutation (UL glioma) |
| PCNSL | BL or UL periventricular (medial thalami); CT hyperdense, T2 hypo-/isointense lesions with low diffusivity and homogeneous enhancement | Solitary or multiple well-defined masses with marked surrounding vasogenic oedema, subependymal spread | Cognitive decline, personality changes, confusion, focal neurological deficits, headache, nausea and vomiting | No definitive laboratory test; CSF cytology and flow cytology may be positive |
| c. Involving both the basal ganglia and the thalami | ||||
| Tubulinopathies | BL fused malformed BG; BL hypertrophic thalamus; hypoplasia of anterior internal capsule | Brainstem hypoplasia; various cerebellar, cortical GM and corpus callosum malformations | Wide spectrum of clinical severity—microcephaly, developmental delay and epilepsy | Detection of genetic mutations |
| NF-1 FASI | BL asymmetric BG, thalamus, brainstem and cerebellum patchy ill-defined T2 hyperintensities without mass effect | Mild T1 hyperintensity; minimal mass effect; rare contrast enhancement | Incidental findings—frequently regress, may reappear, in patients with symptoms and signs related to NF-1 | Detection of genetic mutations |
| Primary familial brain calcifications | BL BG, thalamus (posterolateral), dentate nucleus, subcortical WM calcification on CT; MRI-SW/T2*/T2 hypointense, T1 hyperintense to hypointense | Calcifications in cerebral cortex, cerebellar cortex and brainstem; confluent white matter abnormalities | Abnormal movements, cognitive and psychiatric manifestations with insidious onset | Detection of genetic mutations; exclusion of other disorders |
| Ethylene glycol intoxication | BL symmetric central deep brain (BG, thalamus, hippocampi, amygdala, dorsal brainstem) T2 hyperintensity | BL symmetric central deep brain CT hypodensity; involvement of insulae and cerebellum; mild mass effect; haemorrhage | Initial inebriation is followed by congestive heart failure and then severe acute kidney failure | Metabolic acidosis with high anion gap and osmolal gap, hypocalcaemia |
| ODS—CPM and EPM | CPM: central pons with sparing of corticospinal tracts EPM: BL symmetric putamen, caudate, thalamus, external and extreme capsule—T2 hyperintensity and T1 hypointensity; CT hypodensity | Reduced diffusivity in the early phase; hippocampus, cerebellum and cerebral cortex may be involved; EPM may precede CPM on imaging studies | Neurocognitive changes (delirium), lethargy, quadriparesis, following swift adjustment of hyponatraemia (and other electrolyte abnormalities—chronically debilitated patients) | Initial serum hyponatraemia (or other electrolyte abnormality) that was then rapidly corrected |
| Vigabatrin-associated MRI changes | BL symmetric thalamus T2 hyperintensity and reduced diffusivity | BL symmetric involvement of GP, brainstem tegmentum and cerebellar dentate nucleus | An incidental reversible finding in around 25% of treated infants; hyperkinetic movement disorders and acute encephalopathy in very rare cases | No specific laboratory test; associated with peak vigabatrin dosage |
| Parathyroid hormone disturbances | BL symmetric BG calcifications on CT; MRI-SW/T2*/T2 hypointense, T1 hyperintense to hypointense | BL calcifications in thalamus, subcortical WM, dentate nucleus, cerebral cortex, hippocampus and cerebellar WM; dural and vascular calcifications | An incidental finding, symptoms and signs from the underlying condition (hypoparathyroidism and pseudohypoparathyroidism) | Serum levels of parathyroid hormone, calcium, phosphorus, magnesium, calcitonin |
| CJD | BL or UL putamen and caudate as well as cortical GM (“cortical ribboning”) hyperintensity on DWI and FLAIR images, without thickening or oedema | Involvement of dorsomedial thalami—“hockey stick” sign or posterior thalami—“pulvinar” sign; reduced diffusivity | Rapidly progressive dementia and myoclonus, akinetic mutism, visual signs, extrapyramidal signs | CSF RT-QuIC (real-time quaking-induced conversion of normal prion protein), 14-3-3 CSF assay |
| ADEM | BL asymmetric thalamus and/or BG ill-defined T2 hyperintense lesions, along with patchy T2 hyperintense cerebral WM lesions | Variable contrast enhancement; central elongated spinal cord lesions; diffusivity increased, peripherally low; AHEM: haemorrhagic foci | Abrupt encephalopathy, often following an infection, in paediatric patients—fever, headache, nausea and vomiting, confusion, vision impairment, drowsiness, seizures | No specific laboratory test; MOG antibodies may be present |
| Viral encephalitis | BL asymmetric thalamus and/or BG signal alterations with mild mass effect, frequently also cortical GM—CT hypodense, T2 hyperintense; reduced diffusivity (at least in some parts) | Spinal cord and cauda equina involvement; variable contrast enhancement; haemorrhage | Headache, fever, confusion, seizures, flu-like symptoms, nausea and vomiting, numbness, weakness | Detection of serum antibodies for some viruses, detection of viral RNA or DNA by PCR |
| Cerebral toxoplasmosis | Scattered deep GM CT hypodense enhancing lesions with surrounding vasogenic oedema; “concentric target” sign: alternating dark and bright layers on T2w/FLAIR images; “eccentric target” sign: ring enhancement with eccentric nodule; decreased rCBV | Corticomedullary junction lesions; solitary lesion; high diffusivity of the lesions | Headache, fever, altered mental status in AIDS and other immunocompromised patients; in utero infection | Detection of serum antibodies; very low CD4 count |
| Hypoxic–ischaemic encephalopathy | BL symmetric thalamus, BG, perirolandic cortex, hippocampus decreased diffusivity followed by T2 hyperintensity and CT hypodensity; BL symmetric deep GM T1 hyperintensity, “absent PLIC” sign (neonates) | Dorsal brainstem, anterior vermis (neonates) | Perinatal asphyxia; cardiac arrest, drowning and other causes of anoxia | No specific laboratory test |
| Hypertensive haematoma | UL putamen or/and thalamus – Acute: haemorrhage with mass effect and surrounding hypodensity on CT – Chronic: slit-like cavities with peripheral MRI-SW/T2*/T2 hypointensity | Pons Medial cerebellum BL lesions | Sudden onset altered mental status, speech disorders, weakness, numbness, visual disturbances; acute hypertension | No specific laboratory test |
| PRES | BL near-symmetric to asymmetric posterior cerebral subcortical T2 hyperintensity and increased diffusivity | BL BG, thalamus and anterior frontal involvement; contrast enhancement; low diffusivity—indicative of infarction; “central variant”: predominant brainstem and BG involvement, also thalamus and periventricular WM | Headache, altered mental status, seizures, visual disturbances, nausea/vomiting, focal deficits; associated conditions: acute hypertension (including eclampsia), sepsis, immunosuppressant drugs, chemotherapy | No specific laboratory test |
BL bilateral, WM white matter, WD Wilson disease, GP globus pallidus, HD Huntington disease, PKAN pantothenate kinase-associated neurodegeneration, GM grey matter, UL unilateral, CSF cerebrospinal fluid, anti-CV2/CRMP5 collapsin response mediator protein 5, BG basal ganglia, SWI-MR susceptibility-weighted magnetic resonance imaging, HIV human immunodeficiency virus, CT computer tomography, DWI diffusion-weighted imaging, FLAIR fluid-attenuated inversion recovery, dAVF dural arterio-venous fistula, PCNSL primary central nervous system lymphoma, NF-1 neurofibromatosis type 1, ODS osmotic demyelination syndrome, CPM central pontine myelinolysis, EPM extrapontine myelinolysis, MRI magnetic resonance imaging, CJD Creutzfeldt–Jakob disease, ADEM acute disseminated/demyelinating encephalomyelitis, AHEM acute haemorrhagic encephalomyelitis, MOG myelin oligodendrocyte glycoprotein, RNA ribonucleic acid, DNA deoxyribonucleic acid, PCR polymerase chain reaction, rCBV relative cerebral blood volume, AIDS acquired immunodeficiency syndrome, PLIC posterior limb of the internal capsule, PRES posterior reversible encephalopathy syndrome